Tvardi Therapeutics (TVRD) Live Share Price, Invest From India

Tvardi Therapeutics Stock Performance

as on September 19, 2026 at 2:15 pm IST

Day's Low
Day's High
$1.59
Day's Price Range
$1.66
$1.63
2.45%
Downside
1.84%
Upside
52 Week's Low
52 Week's High
$1.50
52-Week Price Range
$43.65
$1.63
7.98%
Downside
2577.91%
Upside

Tvardi Therapeutics share price movements today

Previous Close: $1.62
Open: $1.63
Volume: 454.8K
Market Cap: $21.6M
Day's Low - High: $1.59 - $1.66
52 Week Low - High: $1.50 - $43.65

Tvardi Therapeutics Historical Returns

1 Month Return: -13.83 %
3 Month Return: -38.4 %
1 Year Return: -95.76 %
3 Year Return: 0 %
5 Year Return: 0 %

Tvardi Therapeutics Stock Fundamentals & Key Indicators

Check Tvardi Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$21.6M

EPS (TTM)

-2.79

Dividend Yield

0.00%

PE Ratio (TTM)

-0.58

Industry PE ratio

-2.37

PEG Ratio

0.013648308351303758

Return On Equity TTM

-145.40%

Tvardi Therapeutics Stock Valuation

Track how Tvardi Therapeutics P/E has moved over time to understand its valuation trends.

Tvardi Therapeutics in the last 5 years

Overview
Trends

Lowest (-1.75x)

March 31, 2026

Industry (-2.37x)

March 31, 2026

Today (-1.75x)

March 31, 2026

Highest (-0.08x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -1.75x

Tvardi Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tvardi Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Tvardi Therapeutics	Buy	$21.6M	NA	-0.58	0.00%	0.00%
Moderna	BUY	$63.1B	-63.24%	-19.81	-12.57%	0.00%
Vertex Pharmaceuticals	BUY	$130.1B	174.21%	29.81	86.04%	0.00%
Regeneron	BUY	$79.7B	21.1%	18.48	84.86%	0.48%

Stock Returns calculator for Tvardi Therapeutics Stock including INR - Dollar returns

The Tvardi Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Tvardi Therapeutics investment value today

Current value as on today

₹4,628

Returns

-₹95,372

(-95.37%)

Returns from Tvardi Therapeutics Stock

-₹95,737 (-95.74%)

Dollar Impact

₹366 (+0.37%)

Analyst Recommendation on Tvardi Therapeutics Stock

Based on 8 analysts

BUY

75.00%

Buy

12.50%

Hold

12.50%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Tvardi Therapeutics. Average target price of $9.14285714285714

Indian Investors' Interest in Tvardi Therapeutics Stock

Search interest for Tvardi Therapeutics Stock has increased by 16% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 22, 2026 to September 21, 2026

Change:16% versus previous 30 day period

Tvardi Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026	Jun 2026
Total Revenue	3	2	-	-	-	2	-	-	-	-
Gross Profit	2	1	0	-	-	2	0	-	-	-
Operating Income	-32	-29	-7	-5	-10	-2	-8	-5	-7	-6
EBITDA	-31	-28	-6	-3	-10	-2	4	-5	-6	-6
Interest Expense	-	1	1	1	2	2	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	-	0
Income Before Tax	-32	-30	-6	-5	-12	-4	4	-5	-6	-6
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-32	-30	-6	-5	-12	-4	4	-5	-6	-6
Net Profit Margin	77.03%	70.96%	0.00%	97.14%	0.00%	100.00%	0.00%	0.00%	0.00%	0.00%

Tvardi Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Mar 2026
Total Revenue	0	13	19	135	23	41	20	7	-
Gross Profit	-47	-62	-93	-	21	34	14	6	0
Operating Income	-59	-77	-111	5	-89	-87	-121	-55	-26
EBITDA	-58	-77	-111	8	-86	-83	-117	-62	-18
Interest Expense	-	-	-	-	-	0	-	8	-
Depreciation	0	0	0	1	1	1	0	0	0
Income Before Tax	-58	-74	-107	7	-88	-85	-118	-71	-18
Income Tax Expense	0	0	0	0	-	-	-	0	-
Net Income	-58	-74	-106	8	-88	-85	-118	-70	-18
Net Profit Margin	-5226.45%	-460.78%	-469.06%	0.00%	93.25%	82.05%	69.32%	88.62%	0.00%

Tvardi Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026	Jun 2026
Net Income	-32	-30	-20	-12	-12	-9	0	-5	-6	-6
Operating Cash Flow	-17	-30	-12	-13	-4	-7	-8	-4	-5	-9
Investing Cash Flow	-30	25	15	2	-	-10	-20	5	4	5
Financing Cash Flow	36	0	0	0	27	-1	22	0	-	-
Change in Cash	-11	-5	2	-10	-6	-20	-13	0	0	-4

Tvardi Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Mar 2026
Net Income	-58	-74	-106	8	-88	-20	-118	-70	-18
Operating Cash Flow	-54	-22	-109	-5	-60	-17	-92	-60	-23
Investing Cash Flow	-35	-82	-30	-20	-4	-22	43	48	-10
Financing Cash Flow	87	110	142	39	46	0	38	-3	22
Change in Cash	-2	5	2	13	-18	-39	-11	-14	-10

Mutual Funds that own Tvardi Therapeutics Stock

Check out the Mutual Funds with significant holdings in Tvardi Therapeutics.

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	2.584222%	344708
TIAA-CREF Funds	0.732494%	97707
Fidelity Commonwealth Trust II	0.718385%	95825
Fidelity Concord Street Trust	0.561671%	74921
Fidelity Salem Street Trust	0.498247%	66461

See all

Global Institutional Holdings in Tvardi Therapeutics

Funds	Holdings
David Gerald Greenspan	5.28%
Vanguard	2.58%
Andrew J.M. Spokes	0.16%

Insights on Tvardi Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 606.0%
NEGATIVE IMPACT
Price Dip
In the last 7 days, TVRD stock has moved down by -12.8%

About Tvardi Therapeutics

Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.

Organisation	Tvardi Therapeutics
Headquarters	3 Sugar Creek Center Boulevard, Sugar Land, TX, 77478, US
Industry	Biotechnology
CEO	Imran Alibhai
E-voting on shares	Click here to vote

Key Management of Tvardi Therapeutics

Name	Title
Mr. David J. Tweardy M.D.	Co-Founder & Scientific Advisory Board Member
Dr. Ronald A. DePinho M.D.	Co-Founder & Chairman of Scientific Advisory Board
Dr. Jeffrey Larson DABT, Ph.D.	Senior Vice President of R&D
Dr. Imran Alibhai Ph.D.	CEO & Director
Mr. Dan Conn J.D., M.B.A.	CFO & Corporate Secretary
Mr. Stephen O'Brien CPA	VP of Finance & Corporate Controller
Dr. Yixin Chen Ph.D.	Vice President of CMC
Dr. John Kauh M.D.	Chief Medical Officer
Dr. Michael T. Lewis Ph.D.	Co-Founder & Scientific Advisory Board Member

FAQs

What is Tvardi Therapeutics share price today?

Tvardi Therapeutics share price today is $1.63 as on September 19, 2026 at 8:45 am IST at the close of the market. Tvardi Therapeutics share today touched a day high of $1.66 and a low of $1.59.

What is the 52 week high and 52 week low for Tvardi Therapeutics share?

Tvardi Therapeutics share touched a 52 week high of $43.65 on January 1, 1970 and a 52 week low of $1.50 on January 1, 1970. Tvardi Therapeutics stock price today i.e. September 19, 2026 at 8:45 am IST is closed at $1.63,which is 96.27% down from its 52 week high and 8.67% up from its 52 week low.

What is Tvardi Therapeutics's market capitalisation today?

Tvardi Therapeutics market capitalisation is $0.00T as on September 19, 2026 at 8:45 am IST.

How to invest in Tvardi Therapeutics Stock (TVRD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tvardi Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tvardi Therapeutics Shares that will get you 0.9202 shares as per Tvardi Therapeutics share price of $1.63 per share as on September 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Tvardi Therapeutics Stock (TVRD) from India?

Indian investors can start investing in Tvardi Therapeutics (TVRD) shares with as little as ₹95.88 or $1 (as of September 21, 2026 at 12:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Tvardi Therapeutics stock (as per the Rupee-Dollar exchange rate as on September 21, 2026 at 12:42 am IST). Based on Tvardi Therapeutics share’s latest price of $1.63 as on September 19, 2026 at 8:45 am IST, you will get 6.1350 shares of Tvardi Therapeutics. Learn more about fractional shares .